Anti-Lung Cancer Drug Tarceva Slows Disease Progression

November 10, 2008

A new study has found that the anti-lung cancer drug Tarceva has succeeded in slowing the progression of the disease.<br /> .....Washington (ChattahBox) – A new study has found that the anti-lung cancer drug Tarceva has succeeded in slowing the progression of the disease.

The drug is being developed and marketed by OSI Pharmaceuticals Inc, Genentech, as well as Roche Holdings.

A new study known as Saturn has shown that the drug is very effective in slowing the progression of lung cancer.

It was done on 889 patients from 160 sites around the world, and was effective after chemotherapy had failed.

The results will soon be submitted to the U.S. Food and Drug Administration.

Once the announcement was made shares of OSI rose by over $5.00.


Comments

One Response to “Anti-Lung Cancer Drug Tarceva Slows Disease Progression”

  1. NEW LUNG CANCER DRUG on December 1st, 2008 5:50 am

    Thousands of lung cancer patients could now live longer and better if they receive a new cancer treatment called Tarceva, a new lung cancer drug. The new lung cancer drug Tarceva works by blocking the complex inside the cell from uniting, so it can’t trigger the production of proteins inside the cell. This slows down the resulting cell division and halts the spread of cancer. For more information about lung cancer and Tarceva visit the website click here, read more about NEW LUNG CANCER DRUG

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.